Low complement levels are related to poor obstetric outcomes in women with obstetric antiphospholipid syndrome. The EUROAPS Registry Study Group
Placenta · 2023
DOI: 10.1016/j.placenta.2023.04.001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Placenta, 2023. Verfasst von Enrique Esteve-Valverde und 32 weiteren Autor:innen. Beteiligte Einrichtung: Systemic Autoimmune Diseases Unit, Department of Internal Medicine, Hospital Universitari Parc Taulí, Sabadell, Spain. Electronic address: Eesteve@ta…. Hauptthemen laut MEDLINE: Antiphospholipid Syndrome, Pregnancy Complications. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 28 Literaturangaben.
Abstract (Originalsprache)
INTRODUCTION: Obstetric antiphospholipid syndrome (OAPS) is an autoimmune disease related to antiphospholipid antibodies (aPL) with primaryinflammatory injury followed by clot cascade activation and thrombus formation. Complement system activation and their participation in aPL-related thrombosis is unclosed. METHODS: We haveanalysed adverse pregnancy outcomes (APO) related to low complement (LC) levels in a cohort of 1048 women fulfilling classification criteria for OAPS. RESULTS: Overall, 223 (21.3%) women presented LC values, during pregnancy. The length of pregnancy was shorter in OAPS women with LC compared to those with normal complement (NC) (median: 33 weeks, interquartile range: [24-38] vs. 35 weeks [27-38]; p = 0.022). Life new-born incidence was higher in patients with NC levels than in those with LC levels (74.4% vs. 67.7%; p = 0.045). Foetal losses were more related to women with triple or double aPL positivity carrying LC than NC values (16.3% vs. 8.0% NC; p = 0.027). Finally, some placental vasculopathies were affected in OAPS patients with LC as late Foetal Growth Restriction (FGR >34 weeks) rise to 7.2% in women with LC vs. 3.2% with NC (p = 0.007). DISCUSSION: Data from our registry indicate that incidence of APO was higher in OAPS women with LC levels and some could be reverted by the correct treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Systemic Autoimmune Diseases Unit, Department of Internal Medicine, Hospital Universitari Parc Taulí, Sabadell, Spain. Electronic address: Eesteve@tauli.cat.
- Systemic Autoimmune Diseases Research Unit, Vall D'Hebron Institut de Recerca (VHIR), Barcelona, Spain; Systemic Autoimmune Disease Unit, Department of Internal Medicine, Vall D'Hebron University Hospital, Barcelona, Sp…
- Vascular and Coagulation Department, University Hospital Angers and CNRS, 6015, INSERM 1083 Unit, Angers, France.
- Systemic Autoimmune Disease Unit, Department of Internal Medicine, Vall D'Hebron University Hospital, Barcelona, Spain.
- Systemic Autoimmune Diseases Research Unit, Vall D'Hebron Institut de Recerca (VHIR), Barcelona, Spain.
- Systemic Autoimmune Diseases Unit, Department of Internal Medicine, Hospital Universitari Parc Taulí, Sabadell, Spain.
Zitieren
APA
Esteve-Valverde, E., Alijotas-Reig, J., Belizna, C., Marques-Soares, J., Anunciacion-Llunell, A., Feijóo-Massó, C., Sáez-Comet, L., Mekinian, A., Ferrer-Oliveras, R., Lefkou, E., Morales-Pérez, S., Hoxha, A., Tincani, A., Nalli, C., Pardos-Gea, J., Marozio, L., Maina, A., Espinosa, G., Cervera, R., …, & Miró-Mur, F. (2023). Low complement levels are related to poor obstetric outcomes in women with obstetric antiphospholipid syndrome. The EUROAPS Registry Study Group. Placenta. https://doi.org/10.1016/j.placenta.2023.04.001
Vancouver
Esteve-Valverde E, Alijotas-Reig J, Belizna C, Marques-Soares J, Anunciacion-Llunell A, Feijóo-Massó C, et al. Low complement levels are related to poor obstetric outcomes in women with obstetric antiphospholipid syndrome. The EUROAPS Registry Study Group. Placenta. 2023. doi:10.1016/j.placenta.2023.04.001
BibTeX
@article{EsteveValverde2023,
author = {Esteve-Valverde, Enrique and Alijotas-Reig, Jaume and Belizna, Cristina and Marques-Soares, Joana and Anunciacion-Llunell, Ariadna and Feijóo-Massó, Carlos and Sáez-Comet, Luis and Mekinian, Arsene and Ferrer-Oliveras, Raquel and Lefkou, Elmina and Morales-Pérez, Stephanie and Hoxha, Ariel and Tincani, Angela and Nalli, Cecilia and Pardos-Gea, Josep and Marozio, Luca and Maina, Aldo and Espinosa, Gerard and Cervera, Ricard and De Carolis, Sara and Latino, Omar and Udry, Sebastian and Llurba, Elisa and Garrido-Gimenez, Carmen and Trespidi, Laura and Gerosa, Maria and Chighizola, Cecilia B and Rovere-Querini, Patrizia and Canti, Valentina and Mayer-Pickel, Karoline and Tabacco, Sara and Arnau, Anna and Miró-Mur, Francesc},
title = {Low complement levels are related to poor obstetric outcomes in women with obstetric antiphospholipid syndrome. The EUROAPS Registry Study Group},
journal = {Placenta},
year = {2023},
doi = {10.1016/j.placenta.2023.04.001}
}
EUVIMED